Dendritic cells and the control of immunity, Nature, vol.7, issue.6673, pp.245-52, 1998. ,
DOI : 10.1016/S1074-7613(00)80531-2
Immunobiology of Dendritic Cells, Annual Review of Immunology, vol.18, issue.1, pp.767-811, 2000. ,
DOI : 10.1146/annurev.immunol.18.1.767
Dendritic cell subsets in primary and secondary T cell responses at body surfaces, Nature Immunology, vol.180, issue.12, pp.1237-1281, 2009. ,
DOI : 10.1084/jem.20041961
Cross-presentation by dendritic cells, Nature Reviews Immunology, vol.195, issue.8, pp.557-69, 2012. ,
DOI : 10.1084/jem.20011644
Ontogeny and Functional Specialization of Dendritic Cells in Human and Mouse, Adv Immunol, vol.120, pp.1-49, 2013. ,
DOI : 10.1016/B978-0-12-417028-5.00001-6
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, Journal of Experimental Medicine, vol.179, issue.4, pp.1109-1127, 1994. ,
DOI : 10.1084/jem.179.4.1109
URL : http://jem.rupress.org/content/jem/179/4/1109.full.pdf
Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation, Immunity, vol.38, issue.2, pp.336-384, 2013. ,
DOI : 10.1016/j.immuni.2012.10.018
URL : https://doi.org/10.1016/j.immuni.2012.10.018
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis, Arthritis Res Ther, vol.8, pp.10-1186, 1864. ,
Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity, Arthritis Research & Therapy, vol.15, issue.5, pp.10-4338, 1186. ,
DOI : 10.1016/j.bbrc.2007.03.081
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response, Journal of Clinical Immunology, vol.20, issue.33, pp.550-557, 2015. ,
DOI : 10.1038/nm.3439
Therapeutic Targeting of the Interleukin-6 Receptor, Annual Review of Pharmacology and Toxicology, vol.52, issue.1, pp.199-219, 2012. ,
DOI : 10.1146/annurev-pharmtox-010611-134715
Differential shedding of the two subunits of the interleukin-6 receptor, FEBS Letters, vol.31, issue.1-2, pp.174-182, 1993. ,
DOI : 10.1016/0165-2478(92)90138-E
The hepatic interleukin-6 receptor Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand, FEBS Letters, vol.139, issue.2-3, pp.219-241, 1992. ,
DOI : 10.1016/0092-8674(89)90607-7
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells, Nature Medicine, vol.191, issue.1, pp.48-54, 2004. ,
DOI : 10.1084/jem.191.3.541
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein, Science, vol.269, issue.5220, pp.81-84, 1995. ,
DOI : 10.1126/science.7541555
A Critical Role for Stat3 Signaling in Immune Tolerance, Immunity, vol.19, issue.3, pp.425-461, 2003. ,
DOI : 10.1016/S1074-7613(03)00232-2
URL : https://doi.org/10.1016/s1074-7613(03)00232-2
Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function, The Journal of Immunology, vol.184, issue.5, pp.2638-2683, 2010. ,
DOI : 10.4049/jimmunol.0902960
URL : http://www.jimmunol.org/content/jimmunol/184/5/2638.full.pdf
Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders, Rheumatology, vol.46, issue.7, pp.1153-1159, 2007. ,
DOI : 10.1093/rheumatology/kem075
URL : https://academic.oup.com/rheumatology/article-pdf/46/7/1153/9449490/kem075.pdf
High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism, vol.41, issue.5, pp.652-659, 2012. ,
DOI : 10.1016/j.semarthrit.2011.08.005
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family, International Immunopharmacology, vol.5, issue.12, pp.1731-1771, 2005. ,
DOI : 10.1016/j.intimp.2005.05.010
Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding, Journal of Biological Chemistry, vol.92, issue.17, pp.14804-14815, 2011. ,
DOI : 10.1523/JNEUROSCI.5221-09.2010
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses, Blood, vol.118, issue.19, pp.5340-5343, 2011. ,
DOI : 10.1182/blood-2011-06-363390
URL : http://www.bloodjournal.org/content/bloodjournal/118/19/5340.full.pdf
Interleukin- 6-type cytokine signalling through the gp130, Jak/STAT pathway. Biochem J, vol.334, issue.2, pp.297-314, 1998. ,
IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation, The Journal of Immunology, vol.173, issue.6, pp.3844-54, 2004. ,
DOI : 10.4049/jimmunol.173.6.3844
URL : http://www.jimmunol.org/content/jimmunol/173/6/3844.full.pdf
p53-mediated delayed NF-??B activity enhances etoposide-induced cell death in medulloblastoma, Cell Death & Disease, vol.3, issue.5, 2010. ,
DOI : 10.1038/msb.2010.6
URL : http://www.nature.com/cddis/journal/v1/n5/pdf/cddis201016a.pdf
Th17 cells in immunity and autoimmunity, Annals of the Rheumatic Diseases, vol.67, issue.Suppl 3, pp.26-35, 2008. ,
DOI : 10.1136/ard.2008.098004
-Infected Erythrocytes, Journal of Interferon & Cytokine Research, vol.33, issue.2, pp.65-71, 2013. ,
DOI : 10.1089/jir.2012.0094
The p38-Mediated Rapid Down-Regulation of Cell Surface gp130 Expression Impairs Interleukin-6 Signaling in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients, Arthritis & Rheumatology, vol.83, issue.Suppl 5, pp.470-478, 2014. ,
DOI : 10.1002/art.30570
The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue, Arthritis & Rheumatism, vol.48, issue.Suppl 2, pp.3284-93, 2011. ,
DOI : 10.1002/art.11160
gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6, Blood, vol.91, pp.3308-3322, 1998. ,
Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer, Cancer Genomics Proteomics, vol.7, pp.287-302, 2010. ,
The soluble interleukin-6 receptor and related proteins, Best Pract Res Clin Endocrinol Metab, vol.29, pp.787-97, 2015. ,
Direct Activation of TACE-Mediated Ectodomain Shedding by p38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation, Molecular Cell, vol.37, issue.4, pp.551-66, 2010. ,
DOI : 10.1016/j.molcel.2010.01.034
TLR4 Mediates MAPK???STAT3 Axis Activation in Bladder Epithelial Cells, Inflammation, vol.12, issue.3, pp.1064-74, 2013. ,
DOI : 10.1179/096805106X102255
IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3, The Journal of Immunology, vol.186, issue.2, pp.1199-208, 2011. ,
DOI : 10.4049/jimmunol.1002971
Cytosolic phospholipase A2 activation by the p38 kinase inhibitor SB203580 in rabbit aortic smooth muscle cells, J Pharmacol Exp Ther, vol.298, pp.331-339, 2001. ,
Dendritic cells from patients with rheumatoid arthritis lack the interleukin 13 mediated increase of Fc??RII expression, which has clear functional consequences, Annals of the Rheumatic Diseases, vol.64, issue.12, pp.1737-43034405, 2004. ,
DOI : 10.1136/ard.2004.034405
Cells of the synovium in rheumatoid arthritis. Dendritic cells, Arthritis Research & Therapy, vol.9, issue.4, 2007. ,
DOI : 10.1186/ar2200
Tocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage, The Journal of Rheumatology, vol.39, issue.6, pp.1192-1199, 2012. ,
DOI : 10.3899/jrheum.111439
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study, Annals of the Rheumatic Diseases, vol.69, issue.01, pp.88-96105197, 2008. ,
DOI : 10.1136/ard.2008.105197
IL-6 in Inflammation, Immunity, and Disease, Cold Spring Harbor Perspectives in Biology, vol.6, issue.10, 2014. ,
DOI : 10.1101/cshperspect.a016295
URL : http://cshperspectives.cshlp.org/content/6/10/a016295.full.pdf